Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1.
Ontology highlight
ABSTRACT: We developed an in vitro method for isolating and expanding autologous CD4+ T-cell clones with specificity for the melanoma-associated antigen NY-ESO-1. We infused these cells into a patient with refractory metastatic melanoma who had not undergone any previous conditioning or cytokine treatment. We show that the transferred CD4+ T cells mediated a durable clinical remission and led to endogenous responses against melanoma antigens other than NY-ESO-1.
SUBMITTER: Hunder NN
PROVIDER: S-EPMC3277288 | biostudies-literature | 2008 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA